Hip Replacement clinical trials at University of California Health
4 in progress, 1 open to eligible people
Quadratus Lumborum Block for Total Hip Arthroplasty
open to eligible people ages 18 years and up
The quadratus lumborum (QL) block is a fascial plane block that has been described to provide analgesia from T7-L3 dermatomes. The investigators aim to evaluate the efficacy of QL blocks in patients undergoing primary total hip arthroplasty (THA).
at UCLA
Insignia™ Hip Stem Outcomes Study
Sorry, in progress, not accepting new patients
The objective of this study is to evaluate the safety and effectiveness of the Insignia™ Hip Stem for global market access and post-market clinical follow-up up to 10 years postoperative.
at UCSF
Multi-Centre Study in Patients Undergoing Total Hip Arthroplasty With the Smith+Nephew CATALYSTEM™ Primary Hip System
Sorry, accepting new patients by invitation only
A Multi-Center Study in Patients Undergoing Total Hip Arthroplasty with the Smith+Nephew CATALYSTEM™ Primary Hip System. The purpose of the study is to assess safety and performance of the CATALYSTEM™ and to support product approval in global markets.
at UCSF
Clinical Follow-up of the Echo Bi-Metric Microplasty Stem for Total Hip Arthroplasty
Sorry, in progress, not accepting new patients
The primary objective of this study is to characterize survivorship of the Echo Bi-Metric Microplasty stem in unilateral or bilateral primary total hip arthroplasty at 5 years postoperative.
at UCSD
Our lead scientists for Hip Replacement research studies include Pamela Chia, MD.
Last updated: